Recommendations for research
The guideline committee has made the following key recommendations for research.
1 Simplifying risk assessment
What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD? [2014]
2 Statin treatment for older people
What is the effectiveness of statin treatment in older people? [May 2023, amended December 2023]
For a short explanation of why the committee made this recommendation for research, see the rationale section on statins for primary prevention of CVD .
Full details of the evidence and the committee's discussion are in evidence review C: statins: efficacy and adverse effects.
3 Lipid-lowering treatment for people with type 1 diabetes
What is the effectiveness of statins and/or other lipid-lowering treatment in people with type 1 diabetes? [May 2023, amended December 2023]
For a short explanation of why the committee made this recommendation for research, see the rationale section on statins for primary prevention of CVD .
Full details of the evidence and the committee's discussion are in evidence review C: statins: efficacy and adverse effects.